Previous 10 |
MasTec (NYSE: MTZ ) is up 5.2% after hours following news that it's heading into the S&P MidCap 400 , replacing United Natural Foods (NASDAQ: UNFI ). More news on: MasTec, Inc., United Natural Foods, Inc., MiMedx Group Inc., Stocks on the move, Energy stocks news, Healthcare stocks ...
NEW YORK , Nov. 7, 2018 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P 500, S&P MidCap 400 and S&P SmallCap 600: S&P MidCap 400 constituent Jack Henry & Associates Inc. (NASD: JKHY) will replace EQT Corp. (NYSE: EQT) in t...
In accompanying articles, I have detailed the worst performing decile of the large cap S&P 500 ( SPY ) and the small-cap S&P 600 ( IJR ). This article examines the worst performing 40 stocks in the S&P 400 Mid-Cap ( MDY ). In October 2018, mid-cap stocks had their worst monthly per...
Distributor United Natural Foods (NASDAQ: UNFI) has bought ailing grocer Supervalu (NYSE: SVU) . Therefore, it is time to ask if UNFI makes money. Moreover, we must ask if UNFI can compete with Amazon (NASDAQ: AMZN) and Kroger (NYSE: KR) . To explain, Kroger is the biggest player in or...
Merger activity decreased last week with five new deals announced and four pending deals closing. We saw one of the largest acquisitions in the software industry with IBM paying a huge premium to acquire Red Hat. We also saw yet another Master Limited Partnership ((MLP)) merge into its General...
News, Short Squeeze, Breakout and More Instantly...
United Natural Foods Inc. Company Name:
UNFI Stock Symbol:
NYSE Market:
United Natural Foods Inc. Website:
2024-07-05 05:18:00 ET Stock Traders Daily has produced this trading report using a proprietary method. This methodology seeks to optimize the entry and exit levels to maximize results and limit risk, and it is also applied to Index options, ETFs, and futures for our subscribers. This...
2024-06-06 16:30:04 ET CFRA analyst issues HOLD recommendation for UNFI on June 6, 2024 02:05PM ET. The previous analyst recommendation was Hold. UNFI was trading at $15.555 at issue of the analyst recommendation. The overall analyst consensus : HOLD. Current analyst...